Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M458Revenue $M50.6Net Margin (%)-97.3Altman Z-Score-1.5
Enterprise Value $M384EPS $-0.8Operating Margin %-95.9Piotroski F-Score5
P/E(ttm)--Beneish M-Score-1.2Pre-tax Margin (%)-97.3Higher ROA y-yY
Price/Book6.410-y EBITDA Growth Rate %--Quick Ratio12.3Cash flow > EarningsY
Price/Sales9.05-y EBITDA Growth Rate %-16.7Current Ratio12.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-32.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-51.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M62.8ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with XNPT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XNPTCharles Brandes 2014-12-31 Buy $5.39 - $8.9
($7.36)
$ 7.30-1%New holding19,700
XNPTGeorge Soros 2011-12-31 Sold Out -0.0016%$3.57 - $6.34
($4.97)
$ 7.3047%Sold Out0
XNPTGeorge Soros 2011-09-30 Reduce$5.95 - $7.72
($7)
$ 7.304%Reduce 38.17%16,200
XNPTGeorge Soros 2011-06-30 Buy $6.05 - $9.31
($7.57)
$ 7.30-4%New holding26,200
XNPTBill Gates 2009-06-30 Sold Out -0.03%$13.58 - $21.66
($18.31)
$ 7.30-60%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XNPT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XNPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Barrett Ronald WCEO 2015-07-15Sell25,000$7.12.82view
WIERENGA WENDALLDirector 2015-05-11Buy5,000$5.6329.66view
RIEFLIN WILLIAM JLDirector 2014-12-10Sell11,010$8.49-14.02view
Barrett Ronald WCEO 2014-12-08Sell7,015$8.36-12.68view
BATES GREGORY TSVP, Regulatory Affairs & QA 2014-12-08Sell14,166$8.35-12.57view
Bosko Gianna MSVP, CLO and Secretary 2014-12-05Sell60,000$8.45-13.61view
BATES GREGORY TSVP, Regulatory Affairs & QA 2014-09-09Sell5,612$5.2638.78view
Freund John GordonDirector 2014-06-03Buy12,500$3.9385.75view
FENTON DENNIS MDirector 2014-05-27Buy3,000$4.0281.59view
FRIEDMAN CATHYDirector 2014-05-27Buy2,600$3.9286.22view

Quarterly/Annual Reports about XNPT:

    News about XNPT:

    Articles On GuruFocus.com
    comment on XNPT Mar 15 2013 
    comment on XNPT Mar 06 2013 
    XenoPort Inc. Reports Operating Results (10-Q) Nov 09 2010 
    XenoPort Inc. Reports Operating Results (10-Q) Aug 06 2010 
    XenoPort Inc. Reports Operating Results (10-Q) May 10 2010 
    Xenoport - A Shaking Ham Hock Feb 07 2010 
    XenoPort Inc. Reports Operating Results (10-Q) Aug 06 2009 
    XenoPort Reports Second Quarter Financial Results Aug 05 2009 
    Weekly Top Insider Buys: Alcoa Inc., ABM Industries Inc., Valhi Inc., XenoPort Inc., and Methode Ele Jul 11 2009 
    XenoPort Inc. Reports Operating Results (10-Q) May 07 2009 

    More From Other Websites
    XenoPort to Release Second Quarter Financial Results on August 5, 2015 Jul 27 2015
    XenoPort to Release Second Quarter Financial Results on August 5, 2015 Jul 27 2015
    XenoPort Announces Initiation by NIAAA of Clinical Trial of HORIZANT in Patients with Alcohol Use... Jun 25 2015
    3 Pharmaceutical Stocks to Sell Now Jun 25 2015
    XenoPort Announces Initiation by NIAAA of Clinical Trial of HORIZANT in Patients with Alcohol Use... Jun 25 2015
    HORIZANT (gabapentin enacarbil) Included in New Expert Recommendations on Prevention and Treatment... Jun 08 2015
    HORIZANT (gabapentin enacarbil) Included in New Expert Recommendations on Prevention and Treatment... Jun 08 2015
    XenoPort to Present New Pooled Data Analyses on HORIZANT (gabapentin enacarbil) at the 2015 SLEEP... Jun 02 2015
    XenoPort to Present New Pooled Data Analyses on HORIZANT (gabapentin enacarbil) at the 2015 SLEEP... Jun 02 2015
    XENOPORT INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles... May 22 2015
    XenoPort to Present at the Jefferies 2015 Global Healthcare Conference May 18 2015
    XenoPort to Present at the Jefferies 2015 Global Healthcare Conference May 18 2015
    XENOPORT INC Financials May 15 2015
    10-Q for XenoPort, Inc. May 09 2015
    XenoPort Q1 Loss Wider-than-Expected; Revenues Miss - Analyst Blog May 07 2015
    XENOPORT INC Files SEC form 10-Q, Quarterly Report May 07 2015
    XenoPort to Present New HORIZANT (gabapentin enacarbil) Data at the American Pain Society 34th... May 07 2015
    XenoPort to Present New HORIZANT (gabapentin enacarbil) Data at the American Pain Society 34th... May 07 2015
    XenoPort reports 1Q loss May 06 2015
    Xenoport Inc Earnings Call scheduled for 5:00 pm ET today May 06 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK